Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Camillo Porta

Showing results (91-100 of 426) with videos related to

Pageof 43
Sort By:
Expert Opinion on Drug Safety|August 18, 2020
Safety evaluation of immune-based combinations in patients with advanced renal cell carcinoma: a systematic review and meta-analysisFrancesco Massari, Veronica Mollica, Alessandro Rizzo, et al.
International Journal of Molecular Sciences|September 10, 2020
Large Extracellular Vesicles-A New Frontier of Liquid Biopsy in OncologyGaetano Pezzicoli, Marco Tucci, Domenica Lovero, et al.
Frontiers in Pharmacology|January 3, 2022
A Glimpse in the Future of Malignant Mesothelioma TreatmentGaetano Pezzicoli, Mimma Rizzo, Martina Perrone, et al.
Oncology Reports|June 10, 2005
Flow cytometric analysis of circulating dendritic cell subsets and intracellular cytokine production in advanced breast cancer patientsSilvia Ferrari, Fabio Malugani, Bianca Rovati, et al.
Expert Opinion on Pharmacotherapy|September 2, 2020
An evaluation of UGN-101, a sustained-release hydrogel polymer-based formulation containing mitomycin-C, for the treatment of upper urothelial carcinomasCamillo Porta, Patrizia Giannatempo, Mimma Rizzo, et al.
Molecular Cancer|December 21, 2016
Choosing the right cell line for renal cell cancer researchKlaudia K Brodaczewska, Cezary Szczylik, Michal Fiedorowicz, et al.
Expert Review of Anticancer Therapy|October 4, 2012
Optimizing further treatment choices in short- and long-term responders to first-line therapy for patients with advanced renal cell carcinomaGiuseppe Procopio, Roberto Sabbatini, Camillo Porta, et al.
British Journal of Cancer|March 14, 2023
The emerging role of PI3K inhibitors for solid tumour treatment and beyondCarmen Belli, Matteo Repetto, Santosh Anand, et al.
Biochimica Et Biophysica Acta. Reviews on Cancer|October 14, 2022
MiT translocation renal cell carcinoma: A review of the literature from molecular characterization to clinical managementMimma Rizzo, Gaetano Pezzicoli, Matteo Santoni, et al.
Frontiers in Oncology|October 26, 2020
Liquid Biopsy as a Tool Exploring in Real-Time Both Genomic Perturbation and Resistance to EGFR Antagonists in Colorectal CancerValeria Internò, Marco Tucci, Gaetano Pezzicoli, et al.
Pageof 43

Showing results (91-100 of 426) with videos related to

Sort By:
Pageof 43
Expert Opinion on Drug Safety|August 18, 2020
Safety evaluation of immune-based combinations in patients with advanced renal cell carcinoma: a systematic review and meta-analysisFrancesco Massari, Veronica Mollica, Alessandro Rizzo, et al.
International Journal of Molecular Sciences|September 10, 2020
Large Extracellular Vesicles-A New Frontier of Liquid Biopsy in OncologyGaetano Pezzicoli, Marco Tucci, Domenica Lovero, et al.
Frontiers in Pharmacology|January 3, 2022
A Glimpse in the Future of Malignant Mesothelioma TreatmentGaetano Pezzicoli, Mimma Rizzo, Martina Perrone, et al.
Oncology Reports|June 10, 2005
Flow cytometric analysis of circulating dendritic cell subsets and intracellular cytokine production in advanced breast cancer patientsSilvia Ferrari, Fabio Malugani, Bianca Rovati, et al.
Expert Opinion on Pharmacotherapy|September 2, 2020
An evaluation of UGN-101, a sustained-release hydrogel polymer-based formulation containing mitomycin-C, for the treatment of upper urothelial carcinomasCamillo Porta, Patrizia Giannatempo, Mimma Rizzo, et al.
Molecular Cancer|December 21, 2016
Choosing the right cell line for renal cell cancer researchKlaudia K Brodaczewska, Cezary Szczylik, Michal Fiedorowicz, et al.
Expert Review of Anticancer Therapy|October 4, 2012
Optimizing further treatment choices in short- and long-term responders to first-line therapy for patients with advanced renal cell carcinomaGiuseppe Procopio, Roberto Sabbatini, Camillo Porta, et al.
British Journal of Cancer|March 14, 2023
The emerging role of PI3K inhibitors for solid tumour treatment and beyondCarmen Belli, Matteo Repetto, Santosh Anand, et al.
Biochimica Et Biophysica Acta. Reviews on Cancer|October 14, 2022
MiT translocation renal cell carcinoma: A review of the literature from molecular characterization to clinical managementMimma Rizzo, Gaetano Pezzicoli, Matteo Santoni, et al.
Frontiers in Oncology|October 26, 2020
Liquid Biopsy as a Tool Exploring in Real-Time Both Genomic Perturbation and Resistance to EGFR Antagonists in Colorectal CancerValeria Internò, Marco Tucci, Gaetano Pezzicoli, et al.
Pageof 43